Showing results (671-680 of 680) with videos related to

Sort By:
Pageof 68
You have reached the last page of results.This site can display upto 680 results.
Mycoses|November 15, 2018
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) projectMatteo Bassetti, Luigia Scudeller, Daniele R Giacobbe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2003
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjectsJohn H Rex, Peter G Pappas, Adolf W Karchmer, et al.
Blood Cancer Journal|June 25, 2025
Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy ConsortiumDanai Dima, Mariola A Vazquez-Martinez, James A Davis, et al.
Intensive Care Medicine|March 21, 2024
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAMMatteo Bassetti, Daniele R Giacobbe, Christina Agvald-Ohman, et al.
Blood Cancer Journal|November 28, 2025
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experienceAimaz Afrough, Danai Dima, Beatrice Razzo, et al.
Medrxiv : the Preprint Server for Health Sciences|March 13, 2026
Shared multicellular injury programs of acute and chronic kidney disease enable mechanistic patient stratificationRobin Fallegger, Sergio A Gomez-Ochoa, Charlotte Boys, et al.
Kidney International|February 27, 2021
Rationale and design of the Kidney Precision Medicine ProjectIan H de Boer, Charles E Alpers, Evren U Azeloglu, et al.
The Lancet. Infectious Diseases|June 20, 2025
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b studyJohan A Maertens, George R Thompson, Andrej Spec, et al.
International Journal of Rheumatic Diseases|April 13, 2026
Cross Cultural Validation of Work Productivity and Activity Impairment Questionnaire in Lupus Patients From Latin AmericaRomina E Nieto, Lucia Hernández, Rosana Quintana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 6, 2019
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research ConsortiumJ Peter Donnelly, Sharon C Chen, Carol A Kauffman, et al.
Pageof 68